159 related articles for article (PubMed ID: 28913696)
1. Clinicopathological Risk Factors for Distant Metastasis in Differentiated Thyroid Carcinoma: A Meta-analysis.
Vuong HG; Duong UNP; Pham TQ; Tran HM; Oishi N; Mochizuki K; Nakazawa T; Hassell L; Katoh R; Kondo T
World J Surg; 2018 Apr; 42(4):1005-1017. PubMed ID: 28913696
[TBL] [Abstract][Full Text] [Related]
2. Cervical Lymph Node Metastases of Papillary Thyroid Carcinoma, in the Central and Lateral Compartments, in Children and Adolescents: Predictive Factors.
Spinelli C; Tognetti F; Strambi S; Morganti R; Massimino M; Collini P
World J Surg; 2018 Aug; 42(8):2444-2453. PubMed ID: 29383423
[TBL] [Abstract][Full Text] [Related]
3. Innovative analysis of distant metastasis in differentiated thyroid cancer.
Chen D; Huang L; Chen S; Huang Y; Hu D; Zeng W; Wang M; Zhou W; Feng H; Wei W; Zhang C; Liu Z; Guo L
Oncol Lett; 2020 Mar; 19(3):1985-1992. PubMed ID: 32194693
[TBL] [Abstract][Full Text] [Related]
4. Clinical Characteristics-Assisted Risk Stratification for Extent of Thyroidectomy in Patients With 1-4 cm Solitary Intrathyroidal Differentiated Thyroid Cancer.
Dong F; Zhou L; Wang S; Mao J; Liu C; Shi W
Front Endocrinol (Lausanne); 2021; 12():790730. PubMed ID: 35211090
[TBL] [Abstract][Full Text] [Related]
5. Clinical and Pathologic Predictors of Lymph Node Metastasis and Recurrence in Papillary Thyroid Microcarcinoma.
Siddiqui S; White MG; Antic T; Grogan RH; Angelos P; Kaplan EL; Cipriani NA
Thyroid; 2016 Jun; 26(6):807-15. PubMed ID: 27117842
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of vascular invasion in differentiated thyroid carcinoma: a systematic review and meta-analysis.
Vuong HG; Kondo T; Duong UNP; Pham TQ; Oishi N; Mochizuki K; Nakazawa T; Hassell L; Katoh R
Eur J Endocrinol; 2017 Aug; 177(2):207-216. PubMed ID: 28566444
[TBL] [Abstract][Full Text] [Related]
7. Multifocality as a prognostic factor in thyroid cancer: A meta-analysis.
Joseph KR; Edirimanne S; Eslick GD
Int J Surg; 2018 Feb; 50():121-125. PubMed ID: 29337178
[TBL] [Abstract][Full Text] [Related]
8. Clinical, Pathological, and Molecular Characteristics Correlating to the Occurrence of Radioiodine Refractory Differentiated Thyroid Carcinoma: A Systematic Review and Meta-Analysis.
Luo Y; Jiang H; Xu W; Wang X; Ma B; Liao T; Wang Y
Front Oncol; 2020; 10():549882. PubMed ID: 33117686
[No Abstract] [Full Text] [Related]
9. Prevalence and Risk of Metastatic Thyroid Cancers and Management Outcomes: A National Perspective.
Al-Qurayshi Z; Sullivan CB; Pagedar N; Lee GS; Tufano R; Kandil E
Laryngoscope; 2021 Jan; 131(1):237-244. PubMed ID: 32574405
[TBL] [Abstract][Full Text] [Related]
10. Enemy Beyond the Wall: Clinicopathological Features of Intrathyroidal Papillary Thyroid Carcinoma (T1-T3a) That Metastasize to Lymph Nodes Without Extrathyroidal Extension.
Tam AA; Ince N; Baser H; Altinboga AA; Kilic M; Topaloglu O; Ozdemir D; Alkan A; Ersoy R; Cakir B
Cancer Invest; 2021 May; 39(5):401-408. PubMed ID: 33650923
[TBL] [Abstract][Full Text] [Related]
11. The prognostic value of primary tumor size in papillary and follicular thyroid carcinoma.
Machens A; Holzhausen HJ; Dralle H
Cancer; 2005 Jun; 103(11):2269-73. PubMed ID: 15856429
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for central neck lymph node metastasis of clinically noninvasive, node-negative papillary thyroid microcarcinoma.
Park JP; Roh JL; Lee JH; Baek JH; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
Am J Surg; 2014 Sep; 208(3):412-8. PubMed ID: 24602323
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for lymph node metastasis (LNM) in patients with papillary thyroid microcarcinoma (PTMC): role of preoperative ultrasound.
Zhao C; Jiang W; Gao Y; Niu W; Zhang X; Xin L
J Int Med Res; 2017 Jun; 45(3):1221-1230. PubMed ID: 28534700
[TBL] [Abstract][Full Text] [Related]
14. BRAF(V⁶⁰⁰E) mutation and its association with clinicopathological features of papillary thyroid microcarcinoma: A meta-analysis.
Ma YJ; Deng XL; Li HQ
J Huazhong Univ Sci Technolog Med Sci; 2015 Aug; 35(4):591-599. PubMed ID: 26223933
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of lymph node metastasis and distant metastasis of thyroid carcinoma.
Machens A; Holzhausen HJ; Lautenschläger C; Thanh PN; Dralle H
Cancer; 2003 Aug; 98(4):712-9. PubMed ID: 12910514
[TBL] [Abstract][Full Text] [Related]
16. Clinical risk factors for central lymph node metastasis in papillary thyroid carcinoma: a systematic review and meta-analysis.
Qu H; Sun GR; Liu Y; He QS
Clin Endocrinol (Oxf); 2015 Jul; 83(1):124-32. PubMed ID: 25130203
[TBL] [Abstract][Full Text] [Related]
17. The role of molecular markers and tumor histological type in central lymph node metastasis of papillary thyroid carcinoma.
Paulson L; Shindo M; Schuff K; Corless C
Arch Otolaryngol Head Neck Surg; 2012 Jan; 138(1):44-9. PubMed ID: 22249628
[TBL] [Abstract][Full Text] [Related]
18. [Invasiveness of papillary thyroid microcarcinoma with BRAF mutation].
Yang X; Liang ZY; Meng C; Liang J; Yu Z; Lin YS
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Aug; 35(4):398-403. PubMed ID: 23987486
[TBL] [Abstract][Full Text] [Related]
19. Impact of major different variants of papillary thyroid microcarcinoma on the clinicopathological characteristics: the study of 1041 cases.
Zhi J; Zhao J; Gao M; Pan Y; Wu J; Li Y; Li D; Yu Y; Zheng X
Int J Clin Oncol; 2018 Feb; 23(1):59-65. PubMed ID: 28744725
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological Features and Prognosis of Papillary Thyroid Microcarcinoma for Surgery and Relationships with the BRAFV600E Mutational Status and Expression of Angiogenic Factors.
Shi C; Guo Y; Lv Y; Nanding A; Shi T; Qin H; He J
PLoS One; 2016; 11(12):e0167414. PubMed ID: 27936049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]